Gottlieb Stephen S, Khatta Meenakshi, Friedmann Erika, Einbinder Lynn, Katzen Scott, Baker Brian, Marshall Joanne, Minshall Stacey, Robinson Shawn, Fisher Michael L, Potenza Matthew, Sigler Brianne, Baldwin Carissa, Thomas Sue Ann
Department of Medicine, University of Maryland School of Medicine, and Baltimore Veterans Administration Medical Center, 21201, USA.
J Am Coll Cardiol. 2004 May 5;43(9):1542-9. doi: 10.1016/j.jacc.2003.10.064.
The goal of this study was to determine the prevalence of depression in an out-patient heart failure (HF) population; its relationship to quality of life (QOL); and the impact of gender, race, and age.
Most studies of depression in HF have evaluated hospitalized patients (a small percentage of the population) and have ignored the influence of various patient characteristics. Although reported depression rates among hospitalized patients range from 13% to 77.5%, out-patient studies have been small, have reported rates of 13% to 42%, and have not adequately accounted for the impact of age, race, or gender.
A total of 155 patients with stable New York Heart Association functional class II, III, and IV HF and an ejection fraction <40% were given questionnaires to assess QOL and depression. These included the Medical Outcomes Study Short Form, the Minnesota Living with Heart Failure questionnaire, and the Beck Depression Inventory (BDI). Depression was defined as a score on the BDI of > or =10.
A total of 48% of the patients scored as depressed. Depressed patients tended to be younger than non-depressed patients. Women were more likely (64%) to be depressed than men (44%). Among men, blacks (34%) tended to have less depression than whites (54%). Depressed patients scored significantly worse than non-depressed patients on all components of both the questionnaires measuring QOL. However, they did not differ in ejection fraction or treatment, except that depressed patients were significantly less likely to be receiving beta-blockers.
Depression is common in patients with HF, with age, gender, and race influencing its prevalence in ways similar to those observed in the general population. These data suggest that pharmacologic or non-pharmacologic treatment of depression might improve the QOL of HF patients.
本研究的目的是确定门诊心力衰竭(HF)患者中抑郁症的患病率;其与生活质量(QOL)的关系;以及性别、种族和年龄的影响。
大多数关于HF患者抑郁症的研究评估的是住院患者(占该人群的一小部分),并忽略了各种患者特征的影响。尽管住院患者中报告的抑郁症发生率在13%至77.5%之间,但门诊研究规模较小,报告的发生率在13%至42%之间,且未充分考虑年龄、种族或性别的影响。
对155例纽约心脏协会功能分级为II、III和IV级且射血分数<40%的稳定HF患者进行问卷调查,以评估QOL和抑郁症。这些问卷包括医学结果研究简表、明尼苏达心力衰竭生活问卷和贝克抑郁量表(BDI)。抑郁症定义为BDI得分≥10分。
共有48%的患者被评定为抑郁。抑郁患者往往比非抑郁患者年轻。女性(64%)比男性(44%)更易患抑郁症。在男性中,黑人(34%)患抑郁症的倾向低于白人(54%)。在测量QOL的两份问卷的所有项目上,抑郁患者的得分均显著低于非抑郁患者。然而,他们在射血分数或治疗方面没有差异,只是抑郁患者接受β受体阻滞剂治疗的可能性显著较低。
抑郁症在HF患者中很常见,年龄、性别和种族对其患病率的影响与在普通人群中观察到的情况相似。这些数据表明,对抑郁症进行药物或非药物治疗可能会改善HF患者的QOL。